DIXIE LEE ZIMMERMAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health FLORENCE, KY NPI 1013527837

General Payments — all program years on this page

$802.50

  • Category: General Payments
  • Program years: PY2021–2022
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $556.94 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $556.9422

By paying entity

Latest program year (PY2022) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $245.566
2022 $556.9422

Records — PY2022 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
886270463 Janssen Pharmaceuticals, Inc $13.08 08/16/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
886270469 Janssen Pharmaceuticals, Inc $14.98 10/04/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442047 ABBVIE INC. $9.42 03/11/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442049 ABBVIE INC. $3.75 03/29/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442051 ABBVIE INC. $9.34 03/31/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442053 ABBVIE INC. $5.03 04/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442055 ABBVIE INC. $6.00 04/22/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442057 ABBVIE INC. $12.99 05/06/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442059 ABBVIE INC. $18.23 05/13/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442061 ABBVIE INC. $13.44 05/19/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442063 ABBVIE INC. $10.33 06/09/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442065 ABBVIE INC. $120.29 06/21/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442067 ABBVIE INC. $7.20 07/14/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442069 ABBVIE INC. $8.00 08/23/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442071 ABBVIE INC. $8.00 09/22/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892442073 ABBVIE INC. $19.05 10/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
925974447 Alkermes, Inc. $10.17 07/13/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
925974449 Alkermes, Inc. $109.87 06/16/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954804815 Teva Pharmaceuticals USA, Inc. $114.48 02/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
956255285 Takeda Pharmaceuticals U.S.A., Inc. $14.62 08/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
956255291 Takeda Pharmaceuticals U.S.A., Inc. $14.91 09/21/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
956255297 Takeda Pharmaceuticals U.S.A., Inc. $13.76 10/19/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.